Michaela successfully defended her master‘s thesis: Investigation of the role of the KEAP1-NRF2 antioxidant pathway in the therapy of secondary acute myeloid leukaemia and completed her master‘s studies at the Faculty of Science of Charles University. 

Michaela has been accepted for PhD studies at the Faculty of Science of Charles University in the field of Molecular and Cell Biology, Genetics, and Virology. Michaela will be studying the role of proteome dynamics in the progression and therapy of blood cell disorders.